DexCom, Inc. (NASDAQ:DXCM) reported Q2 2017 earnings this Afternoon, coming in at ($0.16) per share, beating Wall Street’s estimates of ($0.22) per Share. Revenue for the quarter came in at $170.60 million beating analyst estimates of $166.54 million
Analyst Coverage For DexCom, Inc. (NASDAQ:DXCM)
These are 3 Hold Ratings, 15 Buy Ratings .
The current consensus rating for DexCom, Inc. (NASDAQ:DXCM) is Buy (Score: 2.83) with a consensus target price of $89.47 , a potential (33.85% upside)Recent Insider Trading for DexCom, Inc. (NASDAQ:DXCM)
- On 7/24/2017 Steven Robert Pacelli, EVP, sold 1,450 with an average share price of $69.47 per share and the total transaction amounting to $100,731.50.
- On 7/12/2017 Kevin R. Sayer, CEO, sold 6,000 with an average share price of $71.86 per share and the total transaction amounting to $431,160.00.
- On 7/10/2017 Andrew K. Balo, EVP, sold 3,200 with an average share price of $71.55 per share and the total transaction amounting to $228,960.00.
- On 6/23/2017 Steven Robert Pacelli, EVP, sold 1,450 with an average share price of $78.19 per share and the total transaction amounting to $113,375.50.
- On 6/12/2017 Andrew K. Balo, EVP, sold 3,200 with an average share price of $69.06 per share and the total transaction amounting to $220,992.00.
- On 6/12/2017 Kevin R. Sayer, CEO, sold 6,000 with an average share price of $69.07 per share and the total transaction amounting to $414,420.00.
Recent Trading for DexCom, Inc. (NASDAQ:DXCM) Shares of DexCom, Inc. closed the previous trading session at 66.84 up +0.23 0.35% with 1,516,060 shares trading hands.